-
1
-
-
0032062984
-
Tramadol hydrochloride: An overview of current use
-
Bamigbade TA, Langford RM Tramadol hydrochloride: an overview of current use. Hosp Med. 1998 ; 59: 373-376.
-
(1998)
Hosp Med
, vol.59
, pp. 373-376
-
-
Bamigbade, T.A.1
Langford, R.M.2
-
2
-
-
0026512239
-
Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an atypical opioid analgesic
-
Raffa RB, Friderichs E., Reimann W., et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an atypical opioid analgesic. J Pharmacol Exp Ther. 1992 ; 260: 275-285.
-
(1992)
J Pharmacol Exp Ther
, vol.260
, pp. 275-285
-
-
Raffa, R.B.1
Friderichs, E.2
Reimann, W.3
-
3
-
-
0027429714
-
Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol
-
Raffa RB, Friderichs E., Reimann W., et al. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther. 1993 ; 267: 331-340.
-
(1993)
J Pharmacol Exp Ther
, vol.267
, pp. 331-340
-
-
Raffa, R.B.1
Friderichs, E.2
Reimann, W.3
-
4
-
-
0030463064
-
The basic science aspect of tramadol hydrochloride
-
Raffa RB, Friderichs E. The basic science aspect of tramadol hydrochloride. Pain Rev. 1996 ; 3: 249-271.
-
(1996)
Pain Rev
, vol.3
, pp. 249-271
-
-
Raffa, R.B.1
Friderichs, E.2
-
5
-
-
0030033533
-
Contribution of monoaminergic modulation to the analgesic effect of tramadol
-
Desmeules JA, Piguet V., Collart L., et al. Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br J Clin Pharmacol. 1996 ; 41: 7-12.
-
(1996)
Br J Clin Pharmacol
, vol.41
, pp. 7-12
-
-
Desmeules, J.A.1
Piguet, V.2
Collart, L.3
-
6
-
-
0030842909
-
Nonsteroidal anti-inflammatory drugs, traditional opioids, and tramadol: Contrasting therapies for the treatment of chronic pain
-
Aronson MD Nonsteroidal anti-inflammatory drugs, traditional opioids, and tramadol: contrasting therapies for the treatment of chronic pain. Clin Ther. 1997 ; 19: 420-432.
-
(1997)
Clin Ther
, vol.19
, pp. 420-432
-
-
Aronson, M.D.1
-
7
-
-
33746989258
-
Overview of oral modified-release opioid products for the management of chronic pain
-
Amabile CM, Bowman BJ Overview of oral modified-release opioid products for the management of chronic pain. Ann Pharmacother. 2006 ; 40: 1327-1335.
-
(2006)
Ann Pharmacother
, vol.40
, pp. 1327-1335
-
-
Amabile, C.M.1
Bowman, B.J.2
-
8
-
-
0041909442
-
Recommendations for using opioids in chronic non-cancer pain
-
Kalso E., Allan L., Dellemijn PL, et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain. 2003 ; 7: 381-386.
-
(2003)
Eur J Pain
, vol.7
, pp. 381-386
-
-
Kalso, E.1
Allan, L.2
Dellemijn, P.L.3
-
9
-
-
0142212136
-
The use of long-acting opioids in chronic pain management
-
Vallerand AH The use of long-acting opioids in chronic pain management. Nurs Clin North Am. 2003 ; 38: 435-445.
-
(2003)
Nurs Clin North Am
, vol.38
, pp. 435-445
-
-
Vallerand, A.H.1
-
10
-
-
45949106973
-
Chronic pain of osteoarthritis: Considerations for selecting an extended-release opioid analgesic
-
Gibofsky A., Barkin RL Chronic pain of osteoarthritis: considerations for selecting an extended-release opioid analgesic. Am J Ther. 2008 ; 15: 241-255.
-
(2008)
Am J Ther
, vol.15
, pp. 241-255
-
-
Gibofsky, A.1
Barkin, R.L.2
-
11
-
-
0034871011
-
A systematic review of the associations between dose regimens and medication compliance
-
Claxton AJ, Cramer J., Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001 ; 23: 1296-1310.
-
(2001)
Clin Ther
, vol.23
, pp. 1296-1310
-
-
Claxton, A.J.1
Cramer, J.2
Pierce, C.3
-
12
-
-
58249127833
-
Benefits of extended-release opioid analgesic formulations in the treatment of chronic pain
-
Nicholson B. Benefits of extended-release opioid analgesic formulations in the treatment of chronic pain. Pain Pract. 2008 ; 9: 71-81.
-
(2008)
Pain Pract
, vol.9
, pp. 71-81
-
-
Nicholson, B.1
-
13
-
-
39849098437
-
Advanced formulation design: Improving drug therapies for the management of severe and chronic pain
-
Miller DA, Dinunzio JC, Williams RO III. Advanced formulation design: improving drug therapies for the management of severe and chronic pain. Drug Dev Ind Pharm. 2008 ; 34: 117-133.
-
(2008)
Drug Dev Ind Pharm
, vol.34
, pp. 117-133
-
-
Miller, D.A.1
Dinunzio, J.C.2
Williams III, R.O.3
-
14
-
-
4644357395
-
Efficacy and safety assessment of a novel once-daily tablet formulation of tramadol: A randomised, controlled study versus twice-daily tramadol in patients with osteoarthritis of the knee
-
Mongin G., Yakusevich V., Köpe A., et al. Efficacy and safety assessment of a novel once-daily tablet formulation of tramadol: a randomised, controlled study versus twice-daily tramadol in patients with osteoarthritis of the knee. Clin Drug Investig. 2004 ; 24: 545-558.
-
(2004)
Clin Drug Investig
, vol.24
, pp. 545-558
-
-
Mongin, G.1
Yakusevich, V.2
Köpe, A.3
-
15
-
-
0022497847
-
Bioavailability of enteral tramadol formulations. 1st communication: Capsules
-
Lintz W., Barth H., Osterloh G., et al. Bioavailability of enteral tramadol formulations. 1st communication: capsules. Arzneimittelforschung. 1986 ; 36: 1278-1283.
-
(1986)
Arzneimittelforschung
, vol.36
, pp. 1278-1283
-
-
Lintz, W.1
Barth, H.2
Osterloh, G.3
-
17
-
-
34548728684
-
Pharmacokinetics and dose proportionality of three Tramadol Contramid OAD tablet strengths
-
Karhu D., El- Jammal A., Dupain T., et al. Pharmacokinetics and dose proportionality of three Tramadol Contramid OAD tablet strengths. Biopharm Drug Dispos. 2007 ; 28: 323-330.
-
(2007)
Biopharm Drug Dispos
, vol.28
, pp. 323-330
-
-
Karhu, D.1
Jammal, A.2
Dupain, T.3
-
19
-
-
0020662337
-
Statistical analysis of bioavailability studies: Parametric and nonparametric confidence intervals
-
Steinijans VW, Diletti E. Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals. Eur J Clin Pharmacol. 1983 ; 24: 127-136.
-
(1983)
Eur J Clin Pharmacol
, vol.24
, pp. 127-136
-
-
Steinijans, V.W.1
Diletti, E.2
-
20
-
-
37149028732
-
Tramadol extended-release formulations in the management of pain due to osteoarthritis
-
Mongin G. Tramadol extended-release formulations in the management of pain due to osteoarthritis. Expert Rev Neurother. 2007 ; 7: 1775-1784.
-
(2007)
Expert Rev Neurother
, vol.7
, pp. 1775-1784
-
-
Mongin, G.1
-
21
-
-
34548503599
-
A comparison of the analgesic efficacy of Tramadol Contramid OAD versus placebo in patients with pain due to osteoarthritis
-
Burch F., Fishman R., Messina N., et al. A comparison of the analgesic efficacy of Tramadol Contramid OAD versus placebo in patients with pain due to osteoarthritis. J Pain Symptom Manage. 2007 ; 34: 328-338.
-
(2007)
J Pain Symptom Manage
, vol.34
, pp. 328-338
-
-
Burch, F.1
Fishman, R.2
Messina, N.3
-
22
-
-
37249065725
-
Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (Tramadol Contramid OAD)
-
Fishman RL, Kistler CJ, Ellerbusch MT, et al. Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (Tramadol Contramid OAD). J Opioid Manag. 2007 ; 3: 273-280.
-
(2007)
J Opioid Manag
, vol.3
, pp. 273-280
-
-
Fishman, R.L.1
Kistler, C.J.2
Ellerbusch, M.T.3
-
23
-
-
0032789677
-
Pharmacokinetic properties of tramadol sustained release capsules: 3rd Communication: Investigation of relative bioavailability under steady state conditions
-
Raber M., Schulz HU, Schurer M., et al. Pharmacokinetic properties of tramadol sustained release capsules. 3rd communication: investigation of relative bioavailability under steady state conditions. Arzneimittelforschung. 1999 ; 49: 594-598. (Pubitemid 29334753)
-
(1999)
Arzneimittel-Forschung/Drug Research
, vol.49
, Issue.7
, pp. 594-598
-
-
Raber, M.1
Schulz, H.-U.2
Schurer, M.3
Krupp, S.4
Momberger, H.5
-
24
-
-
33751118259
-
Tramadol extended-release tablets
-
Hair PI, Curran MP, Keam SJ Tramadol extended-release tablets. Drugs. 2006 ; 66: 2017-2027.
-
(2006)
Drugs
, vol.66
, pp. 2017-2027
-
-
Hair, P.I.1
Curran, M.P.2
Keam, S.J.3
-
25
-
-
0033062444
-
Analgesic efficacy and tolerability of tramadol 100mg sustained-release capsules in patients with moderate to severe chronic low back pain
-
Raber M., Hofmann S., Junge K., et al. Analgesic efficacy and tolerability of tramadol 100mg sustained-release capsules in patients with moderate to severe chronic low back pain. Clin Drug Investig. 1999 ; 17: 415-423.
-
(1999)
Clin Drug Investig
, vol.17
, pp. 415-423
-
-
Raber, M.1
Hofmann, S.2
Junge, K.3
-
27
-
-
0029979756
-
Pharmacology and clinical experience with tramadol in osteoarthritis
-
Katz WA Pharmacology and clinical experience with tramadol in osteoarthritis. Drugs. 1996 ; 52: 39-47.
-
(1996)
Drugs
, vol.52
, pp. 39-47
-
-
Katz, W.A.1
-
28
-
-
57149112767
-
Onset of analgesic effect and plasma levels of controlled-release tramadol (Tramadol Contramid once-a-day) 200-mg tablets in patients with acute low back pain
-
Sarbu A., Radulescu F., Robertson S., et al. Onset of analgesic effect and plasma levels of controlled-release tramadol (Tramadol Contramid once-a-day) 200-mg tablets in patients with acute low back pain. J Opioid Manag. 2008 ; 4: 285-292.
-
(2008)
J Opioid Manag
, vol.4
, pp. 285-292
-
-
Sarbu, A.1
Radulescu, F.2
Robertson, S.3
-
30
-
-
77951153290
-
-
Biovail Corporation. http://www.biovail.com/. Accessed January 14, 2009.
-
(2009)
Biovail Corporation
-
-
-
32
-
-
34547196422
-
Single- and multiple-dose bioequivalence of two once-daily tramadol formulations using stereospecific analysis of tramadol and its demethylated (M1 and M5) metabolites
-
Eradiri O., Sista S., Lai JC, et al. Single- and multiple-dose bioequivalence of two once-daily tramadol formulations using stereospecific analysis of tramadol and its demethylated (M1 and M5) metabolites. Curr Med Res Opin. 2007 ; 23: 1593-1604.
-
(2007)
Curr Med Res Opin
, vol.23
, pp. 1593-1604
-
-
Eradiri, O.1
Sista, S.2
Lai, J.C.3
-
33
-
-
41349099452
-
Extended-release tramadol (ULTRAM ER): A pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain
-
Barkin RL Extended-release tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain. Am J Ther. 2008 ; 15: 157-166.
-
(2008)
Am J Ther
, vol.15
, pp. 157-166
-
-
Barkin, R.L.1
|